文献速递造血干细胞移植与细胞治疗

肠道微生物群来源的吲哚类代谢物通过I型干扰素信号通路限制移植物抗宿主病

Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.
PubMed 文献 · Blood · 2018-09-26

研究在同种异体骨髓移植(allo-BMT)小鼠主要组织相容性复合体错配模型中,测试肠道微生物群色氨酸代谢产生的吲哚类代谢物对移植物抗宿主病(GVHD)的保护作用。结果显示吲哚-3-甲醛(ICA)可减轻肠道上皮损伤、减少细菌易位和炎性细胞因子产生,降低GVHD病理和死亡率,同时不损害供者T细胞介导的移植物抗白血病效应,其保护作用依赖于I型干扰素(IFN1)信号。

要点

  • 吲哚-3-甲醛(ICA)可减轻allo-BMT小鼠的GVHD病理和死亡率。
  • ICA不损害供者T细胞介导的移植物抗白血病效应。
  • ICA的保护作用依赖于I型干扰素(IFN1)信号通路。

核心结论

  • 肠道微生物群产生的吲哚类代谢物通过I型干扰素信号通路限制肠道炎症和损伤,并保留抗肿瘤反应,可能为有GVHD风险的BMT患者提供治疗选择。

研究设计与样本

  • 研究在小鼠主要组织相容性复合体错配的同种异体骨髓移植(allo-BMT)模型中测试吲哚类代谢物的保护作用。
  • 通过定植色氨酸酶阳性或阴性的Escherichia coli菌株,或外源性给予吲哚-3-甲醛(ICA)评估吲哚效应。

主要发现

  • ICA治疗减轻肠道上皮损伤、减少跨上皮细菌易位和炎性细胞因子产生,降低GVHD病理和GVHD死亡率,但不损害供者T细胞介导的移植物抗白血病反应。
  • ICA治疗还导致受者株特异性耐受移植的T细胞。
  • 转录谱和基因本体分析表明,ICA给药上调与I型干扰素(IFN1)反应相关的基因。
  • 在缺乏IFN1信号的小鼠中,辐射暴露后ICA的保护作用被消除。

临床怎么用

  • 作者认为,吲哚类代谢物可能为有GVHD风险的BMT患者提供治疗选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The intestinal microbiota in allogeneic bone marrow transplant (allo-BMT) recipients modulates graft-versus-host disease (GVHD), a systemic inflammatory state initiated by donor T cells that leads to colitis, a key determinant of GVHD severity. Indole or indole derivatives produced by tryptophan metabolism in the intestinal microbiota limit intestinal inflammation caused by diverse stressors, so we tested their capacity to protect against GVHD in murine major histocompatibility complex-mismatched models of allo-BMT. Indole effects were assessed by colonization of allo-BMT recipient mice with tryptophanase positive or negative strains of Escherichia coli, or, alternatively, by exogenous administration of indole-3-carboxaldehyde (ICA), an indole derivative. Treatment with ICA limited gut epithelial damage, reduced transepithelial bacterial translocation, and decreased inflammatory cytokine production, reducing GVHD pathology and GVHD mortality, but did not compromise donor T-cell-mediated graft-versus-leukemia responses. ICA treatment also led to recipient-strain-specific tolerance of engrafted T cells. Transcriptional profiling and gene ontology analysis indicated that ICA administration upregulated genes associated with the type I interferon (IFN1) response, which has been shown to protect against radiation-induced intestinal damage and reduce subsequent GVHD pathology. Accordingly, protective effects of ICA following radiation exposure were abrogated in mice lacking IFN1 signaling. Taken together, these data indicate that indole metabolites produced by the intestinal microbiota act via type I IFNs to limit intestinal inflammation and damage associated with myeloablative chemotherapy or radiation exposure and acute GVHD, but preserve antitumor responses, and may provide a therapeutic option for BMT patients at risk for GVHD.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Swimm A, Giver CR, DeFilipp Z, et al. Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease. Blood. 2018. PMID: 30257880. doi:10.1182/blood-2018-03-838193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。